Delivery Order SPE2DX22D0010-SPE2D826FAC86
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Metadate CD Caps 20mg, a medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $7,322.65 with an ultimate completion date of April 25, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Metadate CD Caps 10mg, a medication commonly used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order carries a ceiling value of $2,541.81 and is scheduled for completion by August 27, 2025. The contract was awarded on a competitive basis with no set-aside designation, and performance will be executed from...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,006.19 and an ultimate completion date of August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $16,551.16, represents a non-competitive set-aside award and is scheduled for completion by August 19, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Metadate CD Caps 20mg, a prescription medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $5,961.67, represents a non-set-aside competitive award and is scheduled for completion by July 31, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for Metadate CD Caps 30mg, a methylphenidate-based attention deficit hyperactivity disorder medication. This firm fixed-price delivery order, valued at $6,920.67, is set to be completed by September 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Metadate CD Caps 20mg, a central nervous system stimulant medication used to treat attention deficit hyperactivity disorder. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with a ceiling value of $5,438.69 and an ultimate completion date of April 24, 2025. The performance location is...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for Metadate CD Caps 10mg, a methylphenidate-based medication used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,890.98 and is scheduled for ultimate completion by September 12, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's...
- On July 18, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,295.31 to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of July 21, 2025. The contract is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used for attention deficit hyperactivity disorder treatment. This non-set-aside, competitively awarded contract is valued at $5,541.86 with a firm fixed price structure and an ultimate completion date of August 27, 2025. The order was executed on August 26, 2025, with performance taking place at...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAC86Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 6, 2025, for the supply of Metadate CD Caps 10mg, a medication used to treat attention-deficit/hyperactivity disorder. This is a firm fixed-price delivery order with a ceiling value of $3,203.63 and an ultimate completion date of October 7, 2025. The award is unclassified as a set-aside contract, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems, with a demonstrated track record of fulfilling federal medical supply requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 10/6/25 |